Instead, the best choice is the one you can stay consistent with
Clinical studies consistently show that tirzepatide often leads to greater weight loss and more significant improvements in blood sugar control compared to GLP-1 receptor agonists alone
doi:10.1016/j.jad.2023.10.009 Kuang J, Zhang L, Xu Y, Xue J, Liang S, Xiao J
10.1016/j.tube.2019.04.003 90 Sao EmaniC.WilliamsM
There are minimal BMI requirements to be aware of: An initial BMI of 30 or greater An initial BMI of 27 to 29.9 with at least one additional weight-related health issue such as high blood pressure, high cholesterol or triglycerides, diabetes, or pre-diabetes
Based on the data from population-based registries now available through the Office for Cancer Registry of the National Cancer Center China, about 3,929,000 new cancer cases and 2,388,000 cancer-related deaths were reported in China in 2015 [2]